Direct sequencing demonstrated the presence of an e19a2 BCR-ABL1 fusion with a final diagnosis of chronic phase CML with a high-risk Sokal score of 3.15. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.